Tildacerfont |
| Katalog-Nr.GC65893 |
Tildacerfont ist ein potenter und oral aktiver Corticotropin-Releasing-Factor-Typ-1-(CRF1-)Rezeptorantagonist. Tildacerfont senkt effektiv die Spiegel des adrenocorticotropen Hormons (ACTH) und der Nebennierenandrogene. Tildacerfont hat ein gÜnstiges Sicherheitsprofil. Tildacerfont kann zur Erforschung der angeborenen Nebennierenhyperplasie verwendet werden.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1014983-00-6
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Tildacerfont is a potent and orally active corticotrophin-releasing factor type 1 (CRF1) receptort antagonis. Tildacerfont effectively reduces adrenocorticotropic hormone (ACTH) and adrenal androgen levels. Tildacerfont has favourable safety profile. Tildacerfont can be used for researching congenital adrenal hyperplasia[1].
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *